SESSION 42 SCHEDULE
Sunday
SESSION 42: NEW DEVELOPMENTS, CONCEPTS AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
6:45 AM - 6:50 AM How To Make Ultrasound (Duplex) A Useful Surveillance Tool And Decrease The Number Of CTs After EVAR: Can Duplex Velocity Differences In Graft Limbs Indicate An Endoleak?
 
6:51 AM - 6:56 AM Immune Mediated Coagulopathy: A Complication Of Bovine Thrombin: How Can It Be Recognized, Prevented And Treated?
 
6:57 AM - 7:02 AM Inadvertent Arterial Injury Secondary To Treatment Of Varicose Veins And Venous Insufficiency By Surgery And Foam: Diagnosis And Treatment
 
7:03 AM - 7:08 AM Practical Measures For Radiation Protection During Endovascular Procedures
 
7:09 AM - 7:14 AM How To Manage Infected Carotid Patches
 
7:15 AM - 7:20 AM Computerized Models Of Displacement Forces Can Be Helpful In Predicting Migration Of Endografts After EVAR And Can Help In Graft Selection
 
7:21 AM - 7:26 AM Standardized And Semiautomatic Noninvasive Evaluation Of Carotid Plaque Activity For Predicting Stroke Risk In Asymptomatic Patients: The Activity Index
 
7:27 AM - 7:32 AM Relationship Between Atherosclerotic Plaque Composition By IVUS And Cerebral Embolization
 
7:33 AM - 7:38 AM New Techniques (PET And MSOT [Multispectral Optacoustic Tomography] Scanning) For Imaging Carotid Plaques To Determine Their Vulnerability To Have Strokes: Do They Work In Asymptomatic Patients?
 
7:39 AM - 7:44 AM Spinning Of CREST
 
7:45 AM - 7:50 AM Contrast Enhanced Ultrasound To Identify Asymptomatic Carotid Plaques At Risk For Causing A Stroke
 
7:51 AM - 7:56 AM Carotid Plaque Composition Relates To Symptomatic Status Of Patients And The Incidence Of Restenosis: How Should Plaque Composition Influence Treatment?
 
7:57 AM - 8:02 AM Can Asymptomatic Patients With Carotid Plaques Who Are At High Risk For Stroke Be Identified Noninvasively: The ACSRS Study In > 1,000 Patients
 
8:03 AM - 8:08 AM Novel Technique For Assessing Plaque Risk Noninvasively In Patients With Asymptomatic Carotid Stenoses
 
8:09 AM - 8:13 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 42.1 - Predictors Of Mortality With Open And Endovascular Treatment Of Ruptured AAAs
 
Web-Based Presentation 42.2 - New Concepts In Effort Thrombosis And Neurogenic Thoracic Outlet Syndrome And How They Are Best Treated
 
Web-Based Presentation 42.3 - C. Difficile Colitis Is Associated With Increased Mortality In All Vascular Surgery Patients
 
Web-Based Presentation 42.4 - Multilayer Stent For The Treatment Of Popliteal Aneurysms
 
Web-Based Presentation 42.5 - CAS vs. CEA: Which Is Best For The Surgeon Who Can Do Both Well?
 
Web-Based Presentation 42.6 - CEA Or CAS Should Be Performed In The Acute Period After A TIA Or Minor Stroke Without Increasing Procedural Risk: How Can This Be Done Safely?
 
END OF SESSION 42
 
SESSION 43 SCHEDULE
Sunday
SESSION 43: MORE ABOUT ABDOMINAL AND THORACIC ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
8:18 AM - 8:23 AM Use Of A Large Diameter, Low Profile (8 Fr Delivery System) Balloon Expandable Covered Stent (ADVANTA V12) For The Treatment Of Aortic Coarctation
 
8:24 AM - 8:29 AM New Findings And Interpretations From The CAESAR Small AAA Trial
 
8:30 AM - 8:35 AM New Findings And Interpretations From The PIVOTAL Small AAA Trial
 
8:36 AM - 8:41 AM The Strange Relationship Between Diabetes And AAAs
  Presenters(s):Frank A. Lederle, MD  
8:42 AM - 8:47 AM 10 Top Technical Tips For Performing EVAR With Challenging Anatomy
 
8:48 AM - 8:53 AM Predictors Of Poor Outcomes With EVAR Using NSQIP Database: How Can It Help Us Make Better Clinical Decisions?
 
8:54 AM - 8:59 AM Impact Of Obesity On Treatment Outcomes Of AAA Treatment With EVAR And Open Repair: Should Obesity Influence Choice Of Treatment Methods?
 
9:00 AM - 9:05 AM Panel Discussion
Moderator(s): TBD / TBD  
9:05 AM - 9:10 AM Lessons Learned From Late Retreatment After EVAR Failure
 
9:11 AM - 9:16 AM How Can Theoretical Mathematical And Bench Top Models Of Acute Aortic Dissection Be Helpful?
 
9:17 AM - 9:22 AM When Can The Celiac Axis Be Covered Safely During TEVAR: Can There Be Adverse Outcomes And How Can They Be Predicted?
 
9:23 AM - 9:28 AM Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Must Be Revascularized: The SVS Guidelines Say So
 
9:29 AM - 9:34 AM Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Should Only Be Revascularized Selectively
  Presenters(s):Timothy A. Resch, MD, PhD  
9:35 AM - 9:40 AM Significance Of Air Bubbles In An Aneurysm Sac After TEVAR Or EVAR: How Long Postop Can They Be A Normal Finding?
 
9:41 AM - 9:46 AM Minimal Incisionn Aortic Surgery: An Undertilized But Safe Technique
 
9:47 AM - 9:55 AM Panel Discussion
Coffee Available In 3rd Floor Foyer
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 43.1 - Current Guidelines For Treatment Of Small AAAs
 
Web-Based Presentation 43.2 - Debate: Most Type I Endoleaks Are Dangerous And Must Be Treated
 
Web-Based Presentation 43.3 - Debate: Type I And Type II Endoleaks Are Not Always Dangerous And Some Can Be Observed: Under What Conditions?
 
END OF SESSION 43
 
SESSION 44 SCHEDULE
Sunday
SESSION 44: NEW DEVELOPMENTS IN DISEASES OF THE SUPRA-AORTIC TRUNKS, THE VERTEBRALS AND THE CAROTIDS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
9:56 AM - 10:01 AM Optimal Treatment For Coincident Carotid Or Vertebral Stenosis And Concurrent High-Grade Intracranial Stenosis
 
10:02 AM - 10:07 AM Identifying And Managing The Isolated Cerebral Hemisphere During CAS And CEA
 
10:08 AM - 10:13 AM Takayasu’s Disease Treatment Options: When Is Endovascular Treatment With Stenting Acceptable?
 
10:14 AM - 10:19 AM Are Stent Fractures After Common Carotid And Innominate Stenting Frequent: When Do They Occur And What Should Be Done About Them?
 
10:20 AM - 10:25 AM Long-Term Results Of Vertebral Artery Stenting For Symptomatic Ostial Stenoses: Value And Limitations
 
10:26 AM - 10:31 AM Unusual Application Of Flow Reversal Embolic Protection With Vertebral And Other Lesions
 
10:32 AM - 10:37 AM Can CEA Be Performed Safely On Patients Taking ASA, Plavix And/Or Coumadin Without Stopping The Drugs: Tips And Tricks
 
10:38 AM - 10:43 AM Nationwide US Outcomes For CEA And CAS: Are There Important Differences In Women vs. Men; In Those > 80 vs. Those < 80?
 
10:44 AM - 10:49 AM Have CEA Results Improved Since The Landmark Trials (NASCET, ACAS, Etc.) And Why?
 
10:50 AM - 10:55 AM Debate 29: There Is A Major Role For CAS In Europe And The USA After The Recent Trials
 
10:56 AM - 11:01 AM Debate 29: The Role Of CAS After The Recent Trials Should Be Minimal – Especially In Asymptomatic Patients
 
11:02 AM - 11:08 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 44.1 - Correlation Of Carotid Stump Pressure With Collateral Cerebral Circulation
 
Web-Based Presentation 44.2 - Does Endovascular Treatment Of Takayasu’s Disease Ever Work And When?
 
END OF SESSION 44
 
SESSION 45 SCHEDULE
Sunday
SESSION 45: NEW DEVELOPMENTS IN CAS AND RELATED TECHNIQUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
11:09 AM - 11:14 AM Why All The Landmark Trials Supporting CEA To Prevent Strokes From Carotid Stenosis Are Obsolete: When Is Carotid Intervention Indicated?
 
11:15 AM - 11:20 AM Debate 30: CEA Not CAS Is The Best Treatment For Most Patients With High-Grade Carotid Stenosis
 
11:21 AM - 11:26 AM Debate 30: CAS Not CEA Is The Best Treatment For Most Patients With High Grade Carotid Stenosis
 
11:27 AM - 11:32 AM Debate 30: Best Medical Treatment (BMRX) Should Be The Treatment Of Choice For Most Patients With Asymptomatic Carotid Stenosis: They Do Not Require Prophylactic CEA Or CAS
 
11:33 AM - 11:38 AM CAS vs. CEA: What Are The Relative Results For Symptomatic And Asymptomatic Patients From The SVS Registry?
 
11:39 AM - 11:44 AM Debate 31: No Patient Should Undergo CAS Without Embolic Brain Protection
 
11:45 AM - 11:50 AM Debate 31: Some Patients Should Undergo CAS Without Embolic Brain Protection
 
11:51 AM - 11:56 AM CAS Is The Treatment Of Choice For Post CEA Symptomatic Restenosis: When Is Observation And Medical Treatment Indicated?
 
11:57 AM - 12:08 PM Panel Discussion / Refreshments Available In 3rd Floor Foyer
Moderator(s): TBD / TBD  
12:09 PM - 12:14 PM Current Status Of Gra- Scale Median (GSM) For Detecting Asymptomatic Carotid Plaques At Risk For Causing Stroke: Why Is There Controversy About The Value Of GSM In Assessing Plaque Vulnerability And Risk?
 
12:15 PM - 12:20 PM Is There A Role For CAS In The Presence Of A Carotid String Sign?
 
12:21 PM - 12:26 PM 10 Top Tips For CAS Without Complications
 
12:27 PM - 12:32 PM Subanalysis Of Flow Reversal System (FRS) For Embolic Protection: What Lessons Can Be Learned?
 
12:33 PM - 12:38 PM Comparison Of Filters And Flow Reversal For Brain Protection As Monitored By TCD And DWI MRI
 
12:39 PM - 12:44 PM Why Were The Results Of CREST And ICSS So Different: Therapeutic Implications
 
12:45 PM - 12:50 PM Analysis Of Filter Debris From CAS Procedures: Does It Correlate With Duplex GSM Findings And How Does It Help Choose The Best Means Of Embolic Protection?
 
12:51 PM - 12:56 PM Carotid Stent Fractures: Incidence And Implications
 
12:57 PM - 1:02 PM Open Surgical Technique Getting Exposure Of The ICA To The Base Of The Skull For Aneurysms, etc.: It's Better Than Dislocating The Jaw
 
1:03 PM - 1:10 PM Panel Discussion
Web-Based Presentation 45.1 - How Can The CREST And ICSS Results Be Reconciled?
 
Web-Based Presentation 45.2 - SVS CAS Registry Shows No Difference In Results Between Open And Closed Cell Stents
 
END OF SESSION 45
 
SESSION 46 SCHEDULE
Sunday
SESSION 46: NEW CONCEPTS, ADVANCES, LATE BREAKING TRIALS AND DEVELOPMENTS (4-MINUTE TALKS)
xxxx
Moderators:TBD
x
1:10 PM - 1:15 PM Minimal Aortic Injury After Chest Trauma: Not All Patients Need Repair: A New Classification System
 
1:15 PM - 1:19 PM Current Thinking About The Biology Of AAAs: Is There Any Hope For Medical Treatment To Slow AAA Growth?
  Presenters(s):Matt M. Thompson, MD  
1:20 PM - 1:24 PM Leaving A Temporary Catheter In The AAA Sac After EVAR Permits Diagnosis And Treatment Of Type I And II Endoleaks
 
1:25 PM - 1:29 PM The Unballoon Aortic Dilating Device Improves Endograft Fixation Without Obstructing Flow Or Causing Graft Blow-Down
 
1:30 PM - 1:34 PM Preop Variables Predict Which Type II Endoleak Will Persist And Require Reintervention
 
1:35 PM - 1:39 PM Improved Techniques For Treating Acute SMA Occlusions In The Endovascular Era
 
1:40 PM - 1:44 PM A New Better Prosthetic Vascular Graft That Minimizes Suture Hole Bleeding
 
1:45 PM - 1:49 PM What Is The Role For Controlled Hypotension During TEVAR?
 
1:50 PM - 1:54 PM The Pin-Down Technique For Crossover Access Via An Aortobifemoral Graft With A Sharp Angle
 
1:55 PM - 1:59 PM Long-Term Results Of VAC On Vessel And Prosthesis For The Treatment Of Arterial Graft Infection
 
2:00 PM - 2:06 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 46.1 - A New Simplified System For Measuring Internal Pressures Without A Hardwire Connection
 
Web-Based Presentation 46.2 - Improved Management Of Type II Endoleaks With Coil Embolization
 
Web-Based Presentation 46.3 - Vascular Injuries From Laparoscopic Procedures: Diagnosis And Treatment
 
Web-Based Presentation 46.4 - Advantages Of And Indications For Prasugrel Over Plavix For Platelet Inhibition: When Does It Matter?
 
Web-Based Presentation 46.5 - A New Simplified System To Evacuate Toxic Blood From Ischemic Limbs To Prevent Reperfusion Syndrome After Relief Of Severe Acute Limb Ischemia
 
Web-Based Presentation 46.6 - New Developments In Silver Acetate Impregnated Grafts For Use In Infected Fields
 
END OF SESSION 46
 
SESSION 47 SCHEDULE
Sunday
SESSION 47: NEW CONCEPTS, RECENT ADVANCES AND DEVELOPMENTS (4-MINUTE TALKS)
xxxx
xxxx
Moderators:TBD
x
2:07 PM - 2:11 PM Tips And Tricks For Anterior Lumbar Spine Exposure
 
2:12 PM - 2:16 PM Advantages Of Stent-Grafts In TIPS Procedures
 
2:17 PM - 2:21 PM Comparison Of Brain Microemboli Resulting From CAS With Flow Reversal And CEA
 
2:22 PM - 2:26 PM New Biomarkers Of Activity Levels In Takayasu’s Arteritis: Can They Guide Treatment?
 
2:27 PM - 2:31 PM Percutaneous Device (ROX) To Create An Iliac AV Fistula To Improve Oxygenation For Patients With Hypoxic COPD: Status Of European And U.S. Trials
 
2:32 PM - 2:36 PM Infrainguinal Bypass Surgery For CLI Has Lower Mortality And Morbidity Than Amputation In Risk Matched Patients
 
2:37 PM - 2:41 PM Sideways Movement Of Endografts Is Predictive Of Adverse Events
 
2:42 PM - 2:46 PM In Lower Extremity Revascularization How Important Is Patency?
 
2:47 PM - 2:51 PM How To Predict Which Patients With A Small AAA Are Likely To Require Treatment
 
2:52 PM - 2:56 PM Promising Results Of A Spiral Flow Synthetic Vascular Graft: Theory And 2-Year Fem-Pop Results
 
2:57 PM - 3:01 PM Is EVAR The Treatment Of Choice For Aortoenteric Fistulas: Review Of World Experience
 
3:02 PM - 3:06 PM The Best Way To Treat Aortoiliac Occlusive Disease Is To Create A New Aortic Bifurcation With Covered Balloon Expandable Stent-Grafts
 
3:07 PM - 3:11 PM Role Of PET/CT With FDG Uptake To Assess The Importance Of The Dynamic Inflammatory Process In Arteriosclerosis And How It Can Be Modified By Statins
 
3:12 PM - 3:19 PM Panel Discussion
3:19 PM - 3:30 PM Raffle Prize Drawing For Fully Paid Clinician Attendees. You Must Be Present To Win.
3:30 PM - 3:30 PM Symposium Ends. Come Back Next Year – November 16-20, 2011.
 
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 47.1 - Is Arterial Compression Underestimated In TOS: Why And What Should Be Done About It?
 
Web-Based Presentation 47.2 - What Is The 30-Day, 1-Year And 5-Year Mortality For Open AAA Repair In A Northern European Population Based Study? Does Gender Matter?
 
Web-Based Presentation 47.3 - Anatomic Fixation Of Endografts At The Aortic Bifurcation Enables EVAR Treatment Of Difficult Necks With Good Long-Term Results Without Migration
 
Web-Based Presentation 47.4 - Predictors Of Cardiac Morbidity And Mortality During EVAR
 
Web-Based Presentation 47.5 - Endovascular Techniques To Improve Results With Open Repair For Ruptured AAAs
 
END OF SESSION 47